Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial

Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial

Background: Digoxin is widely used in atrial fibrillation (AF) and heart failure (HF). However, current evidence regarding its association with clinical outcomes is conflicting. Aim: To investigate the relationship between digoxin therapy and adverse outcomes in patients with AF, with or without HF,...

Full description

Bibliographic Details
Main Authors: Michail Botis, Anastasios Kartas, Athanasios Samaras, Evangelos Akrivos, Elena Vrana, Evangelos Liampas, Andreas S. Papazoglou, Dimitrios V. Moysidis, Anastasios Papanastasiou, Amalia Baroutidou, Haralambos Karvounis, Apostolos Tzikas, John Parissis, Stavros G. Drakos, George Giannakoulas
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Hellenic Journal of Cardiology
Subjects:
Atrial fibrillation
Heart failure
Digitalis
Death
Hospitalization
Mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S1109966622001166

Internet

http://www.sciencedirect.com/science/article/pii/S1109966622001166

Similar Items